From treatment towards prevention! Roche (RHHBY.US) launches clinical trials for Alzheimer's Brainshuttle therapy.

date
15/07/2026
Zhtng Cijng APP learned that Roche (RHHBY.US) has announced a key clinical trial plan for its Alzheimer's disease antibody drug, hoping to prove that the drug can delay disease progression before symptoms appear. With competition intensifying, this pharmaceutical giant is racing against Eli Lilly (LLY.US) and Biogen to advance Alzheimer's disease treatment from "treatment" to "prevention" stage.
Latest
See all latestmore